GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 58,572 shares of the company’s stock after buying an additional 2,578 shares during the quarter. Daiwa Securities Group Inc.’s holdings in GE HealthCare Technologies were worth $4,529,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. grew its position in GE HealthCare Technologies by 14.7% during the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after buying an additional 5,693,244 shares during the period. Nuveen Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at about $112,365,000. Trian Fund Management L.P. acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at about $109,092,000. Ameriprise Financial Inc. grew its position in shares of GE HealthCare Technologies by 84.4% in the third quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company’s stock valued at $181,578,000 after purchasing an additional 1,221,436 shares during the period. Finally, Barclays PLC acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at about $92,462,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.6 %

Shares of GEHC stock opened at $84.49 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a market capitalization of $38.56 billion, a P/E ratio of 27.98, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94. The company has a 50 day moving average price of $88.74 and a 200 day moving average price of $77.82. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 earnings per share. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on GEHC shares. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. Mizuho lifted their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, April 11th. Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. HSBC assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 target price on the stock. Finally, Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.